GB1003802A
(en)
*
|
1963-06-04 |
1965-09-08 |
Searle & Co |
Pyrimidinone derivatives
|
GB1062357A
(en)
*
|
1965-03-23 |
1967-03-22 |
Pfizer & Co C |
Quinazolone derivatives
|
DE2027645A1
(de)
*
|
1970-06-05 |
1971-12-09 |
Byk Gulden Lomberg Chemische Fa bnk GmbH, 7750 Konstanz |
Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
|
US3900476A
(en)
*
|
1973-05-17 |
1975-08-19 |
Upjohn Co |
2(2'-pyrimidylamino)quinazolines and their preparation
|
US3959279A
(en)
*
|
1974-01-28 |
1976-05-25 |
Sandoz, Inc. |
1-Substituted-2-imino-quinazolin-4(1H)ones
|
US3936453A
(en)
*
|
1974-01-28 |
1976-02-03 |
Sandoz, Inc. |
1-Substituted-2-disubstituted aminoquin azolin-4(1h)-ones
|
US4113637A
(en)
*
|
1974-09-10 |
1978-09-12 |
Institut Francais Du Petrole |
Alkyl-guanidino-heterocyclic compounds, their manufacture and use as additives for fuels and lubricants
|
GB8429739D0
(en)
*
|
1984-11-24 |
1985-01-03 |
Fbc Ltd |
Fungicides
|
US5756502A
(en)
*
|
1994-08-08 |
1998-05-26 |
Warner-Lambert Company |
Quinazolinone derivatives as cholyecystokinin (CCK) ligands
|
WO1997010221A1
(en)
*
|
1995-09-15 |
1997-03-20 |
Torrey Pines Institute For Molecular Studies |
Synthesis of quinazolinone libraries
|
US6258819B1
(en)
*
|
1999-08-05 |
2001-07-10 |
Syntex (U.S.A.) Llc |
Substituted 2(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)-4(3H)-azaquinazolinones
|
US7671200B2
(en)
*
|
1999-10-27 |
2010-03-02 |
Cytokinetics, Inc. |
Quinazolinone KSP inhibitors
|
US6545004B1
(en)
|
1999-10-27 |
2003-04-08 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
US7230000B1
(en)
|
1999-10-27 |
2007-06-12 |
Cytokinetics, Incorporated |
Methods and compositions utilizing quinazolinones
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
KR100785363B1
(ko)
*
|
2000-04-25 |
2007-12-18 |
이코스 코포레이션 |
인간 포스파티딜-이노시톨 3-키나제 델타의 억제제
|
WO2002094790A1
(fr)
*
|
2001-05-23 |
2002-11-28 |
Mitsubishi Pharma Corporation |
Compose heterocyclique condense et son utilisation medicale
|
US7060705B2
(en)
|
2001-11-07 |
2006-06-13 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
US6753428B2
(en)
*
|
2001-11-20 |
2004-06-22 |
Cytokinetics, Inc. |
Process for the racemization of chiral quinazolinones
|
US7009049B2
(en)
*
|
2002-02-15 |
2006-03-07 |
Cytokinetics, Inc. |
Syntheses of quinazolinones
|
AU2003223786A1
(en)
*
|
2002-05-09 |
2003-11-11 |
Cytokinetics, Inc. |
Compounds, methods and compositions
|
US7214800B2
(en)
*
|
2002-05-09 |
2007-05-08 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
US7038048B2
(en)
*
|
2002-05-23 |
2006-05-02 |
Cytokinetics, Inc. |
3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use
|
US7041676B2
(en)
*
|
2002-06-14 |
2006-05-09 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
WO2004009036A2
(en)
*
|
2002-07-23 |
2004-01-29 |
Cytokinetics, Inc. |
Compounds compositions and methods
|
JP2005536553A
(ja)
*
|
2002-08-21 |
2005-12-02 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物および方法
|
EP1558083A4
(en)
*
|
2002-09-30 |
2008-04-16 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
CN1894234A
(zh)
*
|
2003-03-25 |
2007-01-10 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
KR20060041309A
(ko)
|
2003-08-13 |
2006-05-11 |
다케다 야쿠힌 고교 가부시키가이샤 |
4-피리미돈 유도체 및 펩티딜 펩티다제 저해제로서의 그의용도
|
WO2005016348A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Method of inhibiting immune responses stimulated by an endogenous factor
|
US20050054614A1
(en)
*
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
WO2005030751A2
(en)
*
|
2003-09-08 |
2005-04-07 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
EP1699777B1
(en)
*
|
2003-09-08 |
2012-12-12 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2005041888A2
(en)
*
|
2003-11-03 |
2005-05-12 |
Cytokinetics, Inc. |
Pyrimidin-4-one compounds, compositions and methods
|
WO2005046588A2
(en)
*
|
2003-11-07 |
2005-05-26 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
WO2005061460A1
(en)
*
|
2003-12-08 |
2005-07-07 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
CN102134231B
(zh)
|
2004-03-15 |
2020-08-04 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
WO2005113554A2
(en)
|
2004-05-13 |
2005-12-01 |
Icos Corporation |
Method of preparing 3-phenyl-2-[9h-purin-6-ylamino)-methyl]-3h-quinazolin-4-one and substituted and related compounds
|
WO2005117889A1
(en)
*
|
2004-05-25 |
2005-12-15 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic
|
EP1828192B1
(en)
|
2004-12-21 |
2014-12-03 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US20080287469A1
(en)
*
|
2005-02-17 |
2008-11-20 |
Diacovo Thomas G |
Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation
|
DE102005024017A1
(de)
*
|
2005-05-25 |
2006-11-30 |
Merck Patent Gmbh |
Chinazolinone
|
WO2007033265A1
(en)
*
|
2005-09-14 |
2007-03-22 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors for treating diabetis
|
ME02005B
(me)
|
2005-09-14 |
2012-08-31 |
Takeda Pharmaceuticals Co |
Inhibitori dipeptidil peptidaze za lečenje dijabetesa
|
EP1924567B1
(en)
*
|
2005-09-16 |
2012-08-22 |
Takeda Pharmaceutical Company Limited |
Process for the preparation of pyrimidinedione derivatives
|
WO2007110868A2
(en)
*
|
2006-03-28 |
2007-10-04 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
EP1999108A1
(en)
*
|
2006-03-28 |
2008-12-10 |
Takeda Pharmaceutical Company Limited |
Preparation of (r)-3-aminopiperidine dihydrochloride
|
KR20090088854A
(ko)
*
|
2006-09-13 |
2009-08-20 |
다케다 야쿠힌 고교 가부시키가이샤 |
2-6-(3-아미노-피페리딘-엘-일)-3-메틸-2,4-디옥소-3,4-디하이드로-2h-피리미딘-1-일메틸-4-플루오로-벤조니트릴의 용도
|
US8324383B2
(en)
|
2006-09-13 |
2012-12-04 |
Takeda Pharmaceutical Company Limited |
Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
|
TW200838536A
(en)
*
|
2006-11-29 |
2008-10-01 |
Takeda Pharmaceutical |
Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
|
US8093236B2
(en)
|
2007-03-13 |
2012-01-10 |
Takeda Pharmaceuticals Company Limited |
Weekly administration of dipeptidyl peptidase inhibitors
|
US20100202963A1
(en)
|
2008-11-13 |
2010-08-12 |
Gallatin W Michael |
Therapies for hematologic malignancies
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
NZ595307A
(en)
|
2009-03-24 |
2013-11-29 |
Gilead Calistoga Llc |
Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
|
US8546409B2
(en)
*
|
2009-04-20 |
2013-10-01 |
Gilead Calistoga Llc |
Methods of treatment for solid tumors
|
CN102647987A
(zh)
|
2009-07-21 |
2012-08-22 |
吉里德卡利斯托加公司 |
使用pi3k抑制剂治疗肝脏障碍
|
WO2012140642A1
(en)
|
2011-04-10 |
2012-10-18 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
EP2834241B1
(en)
|
2012-03-05 |
2020-11-18 |
Gilead Calistoga LLC |
Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
|
ES2752552T3
(es)
|
2013-12-20 |
2020-04-06 |
Gilead Calistoga Llc |
Métodos de proceso para inhibidores de fosfatidilinositol 3-quinasa
|
WO2015095605A1
(en)
|
2013-12-20 |
2015-06-25 |
Gilead Calistoga Llc |
Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one
|
SG11201609877XA
(en)
|
2014-06-13 |
2016-12-29 |
Gilead Sciences Inc |
Phosphatidylinositol 3-kinase inhibitors
|